Anterior Cutaneous Nerve Entrapment Syndrome (ACNES).
Conditions
Interventions
Control: free hand lidocaine injection therapy
Intervention: ultrasound guided lidocain injection therapie
Sponsors
No sponsor
Eligibility
Inclusion criteria
Inclusion criteria: All adult patients (> 18 years) were eligible when suspected for an abdominal wall pain syndrome if all of the following criteria were met: • Single tender point (trigger point); • Constant site of abdominal tenderness with a small ( < 2 cm) area of maximal intensity situated within the lateral boundaries of the rectus abdominis muscle; • Tenderness increases by abdominal muscle tensing, using the Carnett’s test;
Exclusion criteria
Exclusion criteria: Recent intra-abdominal pathology, lidocaine allergy, earlier treatment for ACNES, pregnancy and if adequate follow-up can’t be obtained. Informed consent was obtained if patient characteristics fulfilled these criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint was the proportion of patients achieving at least 50 % reduction in pain perception measured on a Numeric Rating Scale (NRS) 15 minutes after the injection compared to directly before. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints were the effect of the injection regimen on the long term (after 3 months) and the role of the location of the fluid depot (beneath muscle fascia or not). | — |
Contacts
Public ContactMonica Jacobs
Maxima Medisch Centrum
Outcome results
None listed